157 related articles for article (PubMed ID: 728750)
1. Dialysis encephalopathy: recovery after interruption of aluminium intake.
Poisson M; Mashaly R; Lebkiri B
Br Med J; 1978 Dec; 2(6152):1610-1. PubMed ID: 728750
[No Abstract] [Full Text] [Related]
2. Aluminium encephalopathy: a potential risk of aluminium gels in children with chronic renal failure.
Pillion G; Loirat C; Blum C; Poisson M; Bacri JL; Broyer M; Mathieu H
Int J Pediatr Nephrol; 1981 Mar; 2(1):29-32. PubMed ID: 7333766
[No Abstract] [Full Text] [Related]
3. Reversible dialysis encephalopathy: role for aluminium-containing gels.
Masselot JP; Adhemar JP; Jaudon MC; Kleinknecht D; Galli A
Lancet; 1978 Dec 23-30; 2(8104-5):1386-7. PubMed ID: 82892
[No Abstract] [Full Text] [Related]
4. [Treatment of dialysis encephalopathy with deferoxamine].
Starkstein S; Berthier M; Nogués M; Leiguarda R
Medicina (B Aires); 1986; 46(3):327-31. PubMed ID: 3574092
[No Abstract] [Full Text] [Related]
5. [Serum aluminum in hemodialysis patients. Relation to osteodystrophy, encephalopathy and aluminum hydroxide consumption].
Nielsen LP; Heaf JG
Ugeskr Laeger; 1983 May; 145(18):1363-7. PubMed ID: 6868163
[No Abstract] [Full Text] [Related]
6. Brain-aluminium concentration in dialysis encephalopathy.
McDermott JR; Smith AI; Ward MK; Parkinson IS; Kerr DN
Lancet; 1978 Apr; 1(8070):901-4. PubMed ID: 76845
[TBL] [Abstract][Full Text] [Related]
7. Risk of orally administered aluminium hydroxide and results of withdrawal.
Bournerias F; Monnier N; Reveillaud RJ
Proc Eur Dial Transplant Assoc; 1983; 20():207-12. PubMed ID: 6657657
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of aluminium toxicity in a 'low incidence' area.
Winney RJ; Cowie JF; Cumming AD; Short AI; Smith GD; Robson JS
Contrib Nephrol; 1984; 38():47-58. PubMed ID: 6713900
[No Abstract] [Full Text] [Related]
9. Dialysis encephalopathy in a non-dialysed uraemic boy treated with aluminium hydroxide orally.
Nathan E; Pedersen SE
Acta Paediatr Scand; 1980 Nov; 69(6):793-6. PubMed ID: 7211365
[TBL] [Abstract][Full Text] [Related]
10. The dialysis encephalopathy syndrome. Possible aluminum intoxication.
Alfrey AC; LeGendre GR; Kaehny WD
N Engl J Med; 1976 Jan; 294(4):184-8. PubMed ID: 1244532
[TBL] [Abstract][Full Text] [Related]
11. [Prolonged and reversible encephalopathy in a chronic haemodialysis patient. Probable responsibility of aluminium salts (author's transl)].
Buge A; Poisson M; Masson S; Bleibel JM; Lafforgue B; Raymond P; Jaudon MC
Nouv Presse Med; 1978 Jun; 7(23):2053-9. PubMed ID: 673773
[TBL] [Abstract][Full Text] [Related]
12. Aluminum toxicity in relation to kidney disorders.
King SW; Savory J; Wills MR
Ann Clin Lab Sci; 1981; 11(4):337-42. PubMed ID: 7023347
[TBL] [Abstract][Full Text] [Related]
13. [Reversible dialytic encephalopathy after interruption of aluminium intake. 6 cases (author's transl)].
Buge A; Poisson M; Masson S; Bleibel JM; Mashaly R; Jaudon MC; Lafforgue B; Lebkiri B; Raymond P
Nouv Presse Med; 1979 Sep; 8(34):2729-33. PubMed ID: 493078
[TBL] [Abstract][Full Text] [Related]
14. [The natural history of dialysis encephalopathy (author's transl)].
Pogglitsch H; Wawschinek O; Holzer H; Petek W; Ladurner G; Katschnig H; Korthals C
Acta Med Austriaca; 1980; 7(3):71-6. PubMed ID: 7223340
[TBL] [Abstract][Full Text] [Related]
15. Aluminium toxicity during regular haemodialysis.
Elliott HL; Dryburgh F; Fell GS; Sabet S; Macdougall AI
Br Med J; 1978 Apr; 1(6120):1101-3. PubMed ID: 638617
[TBL] [Abstract][Full Text] [Related]
16. Hypercalcaemic osteomalacia and encephalopathy due to aluminium intoxication in haemodialysis patients. Clinical aspects and treatment with desferrioxamine.
Mudde AH; Roodvoets AP; Van Groningen K
Neth J Med; 1985; 28(1):6-11. PubMed ID: 3974771
[No Abstract] [Full Text] [Related]
17. [EEG pattern indicative of dialysis encephalopathy].
Dobato JL; Caminero AB
Neurologia; 1999 Jan; 14(1):35. PubMed ID: 10079690
[No Abstract] [Full Text] [Related]
18. Treatment of early stages of dialysis encephalopathy by aluminium depletion.
Pogglitsch H; Petek W; Wawschinek O; Holzer W
Lancet; 1981 Dec; 2(8259):1344-5. PubMed ID: 6118738
[No Abstract] [Full Text] [Related]
19. Acute aluminum encephalopathy in an uremic patient.
Campistol JM; Cases A; Botey A; Revert A
Nephron; 1989; 51(1):103-6. PubMed ID: 2783763
[TBL] [Abstract][Full Text] [Related]
20. Aluminium encephalopathy.
Bates D; Parkinson IM; Ward MK; Kerr DN
Contrib Nephrol; 1985; 45():29-41. PubMed ID: 3979053
[No Abstract] [Full Text] [Related]
[Next] [New Search]
